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Abstract
Clay nanoparticles are among the most applicable and cost-affordable materials, all 
of which have a variety of applications in case of medical science. In this chapter, key 
characteristics of the clay nanoparticles along with their major groups, structure, mor-
phology, and physicochemical properties were evaluated. Thereafter, the applications of 
clay nanoparticles in the field of nanocomposite, polymeric matrices, and medicine were 
investigated, while specimen production procedures were also reviewed. The main focus 
of this chapter is to investigate the applications of clay nanoparticles in bio- and medical 
science. In fact, organically modified clay nanoparticles (organoclays) are an attractive 
class of hybrid organic–inorganic nanomaterials with potential applications in case of 
polymer nanocomposites, rheological properties modification, and drug delivery carrier.
Keywords: clay nanoparticle, bioapplication, medicine, nanocomposite
1. Introduction
Clay nanoparticles are natural materials in nanoscale that originate from clay. They have 
attracted much attention in recent years due to their widespread applications. The interest 
in exploiting clay nanoparticles for various purposes is due to their high surface and unique 
physical and chemical properties.
In 2013, a group of researchers focused on clay nanoparticles as a drug delivery system. 
Preparation, physical/chemical properties, and bioaccumulation of clay nanoparticles based 
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on drug delivery systems, as well as their application in the food system as a nanocarrier for 
vitamins, antioxidants, linoleic acid, and the other foods, were discussed [1]. In addition, studies 
have shown that nanotechnology will revolutionize the food industry [2]. Nanoscale food con-
trol can lead to the correction of micromolecular properties of foods such as taste, aroma, texture, 
sensory characteristics, processing ability and stability throughout the process, and storage. 
Nanotechnology applications grow rapidly in the food and ingredient sector. Advanced nano-
electronics, in combination with good nanomaterials and intelligent biological components, are 
able to develop very specific and selective measuring devices to identify potentially hazardous 
agents, including viruses, pathogenic microorganisms, as well as inappropriate physical and 
chemical substances in foods [3–5]. The micro/nanotechnology accelerates the decreasing size 
of the sensor to the extent appropriate for application (applied field) [6–8].
In addition to ensuring food safety, nanotechnology improves our lives by monitoring quality 
and nutrition status [9, 10]. Food packaging is another area that has used nanomaterials to 
increase the shelf life of the food by improving the preserving properties. Nylon-based nano-
composites are currently used to produce beverage bottles in Korea and the United States 
[11]. Polymer nanoparticles are made by dispersing nanoparticles into a polymer matrix [12]. 
For example, nylon/silicate nanocomposite containing 2% non-mineral nanoparticle has two 
times higher tensile strength and thermal stability (at a temperature above 100°C) than pure 
nylon [12]. Nylon-based nanocomposites are formed by the dispersion of silicate layers on 
a continuous polymer matrix. This structure significantly reduces the amount of oxygen or 
carbon dioxide release (diffusion) in encapsulation, since these gases should be distributed 
through the space between dispersed nano-silicate layers [13]. Properties such as strength and 
thermal stability make this nanocomposite ideal for packaging food. Several attempts and 
experiments have been carried out to provide various types of antioxidants, nutrients, miner-
als, drugs, and other applicable factors through food [14]. Currently, most efforts to develop 
delivery systems focus on drugs. While safety and cost concerns are one of the most important 
factors in choosing food for the customer, high production costs of drug delivery systems are 
still acceptable in medicine. Clay nanoparticles are minerals in clay that have attracted much 
attention due to the biological application of their abundance in nature, simplicity of construc-
tion, and biocompatibility [15–18]. Clay nanoparticles also have a great potential for nutrition 
because they have been used to treat and protect as a traditional medicine since the beginning 
of human civilization [19–21]. Clay minerals have been used as laxatives, antidiarrhea, anti-
inflammatory agents, blood purification, reducing infections, and healing of stomach ulcers 
[22]. In addition, biocompatible clay minerals are currently used as oral antioxidants [23, 24]. 
Clay nanoparticles have unique layer structures, including the accumulation of nanoparticles 
with metal ions and intracellular ions for charge balancing [25]. The two-dimensional (2D) 
structure illustrates interesting strategies for the development of new nano-hybrid systems by 
enhancing active biochemical molecules into space (Figure 1). Intrinsically, unstable agents 
can be protected against processing conditions and hard-working environment and ulti-
mately released with a controlled pattern in a desirable environment [26–28]. Many studies 
have shown that nano-layered materials can encapsulate DNA [29, 30], nucleotides [31, 32], 
drugs [33, 34], proteins [35], and even viruses [36]. These nano-hybrid systems are designed to 
enhance the efficient delivery to cells and the effectiveness of biochemical molecules [37–39]. 
However, the application of nanoscale materials to nutrients delivery is very limited.
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2. Delivery efficiency and biocompatibility of clay nanoparticles
2.1. Structural and physical properties of nanoclays
Nanoclays are fine-grained crystalline materials. A layer is the basic structural unit of nano-
clays, and these layers are prone to arrange themselves over one another like pages of a 
book. Individual layers are composed of the tetrahedral and/or octahedral sheets, and this 
arrangement of sheets plays a vital role in defining and distinguishing these clay minerals. 
In tetrahedral sheet, the silicon-oxygen tetrahedra are linked to neighboring tetrahedra by 
sharing three corners while the fourth corner of each tetrahedron forms a part to the adjacent 
octahedral sheet. The octahedral sheet is usually composed of aluminum or magnesium in a 
sixfold coordination with oxygen from the tetrahedral sheet and with hydroxyl.
2.2. Structural features
Clay layer nanoparticles are divided into two different types of anion and cation depend-
ing on the level of layer charge and the types of interlayer ions. Anionic layer nanomaterials 
typically have been created by double-layered hydroxides (LDHs) with alterable anions in 
interlayer spaces. LDHs include a wide range of chemical compounds and their layered struc-
ture that can be of a great variety to produce poly-types. For example, aluminosilicate cationic 
nanoparticles like montmorillonite (MMT) have octagonal and quadrilateral plates with high 
internal surfaces. The main structure of cationic clays is based on a framework, where the 
unit structure is composed of an octagonal-twisted sheet between two quadrilateral plates. In 
Figure 2, the structure of the double-layer hydroxide and cationic clay (MMT) is presented.
Therefore, cationic and anionic clay nanoparticles can be applied as transfer carriers, which 
depend on the charge of molecules and essentially on their unique layered structure.
2.3. Biocompatibility
In general, clay nanoparticles are considered as biodegradable materials. In fact, cationic 
minerals have traditionally been applied in a variety of fields including skin chemotherapy, 
laxatives, antidiarrhea, and anti-inflammatory agents as well as antimicrobial agents [40–42]. 
Recently, they are used as lubricants and distributary in pharmaceutical programs to improve 
chemical, physical, and organoleptic properties [43–45]. MMT can be considered as an 
Figure 1. A scheme of clay-layered nanomaterial systems [1].
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eco-friendly cationic clay [46], which is commonly used in many pharmaceutical formulations 
as an active and additive substance [47]. In addition, anionic nanoparticles of LDH in carbon-
ate form are used as an antacid agent (antipepsin) to neutralize gastric acid, which is related 
to its alkaline properties under physiological pH [48]. The results show that LDH has a lower 
toxicity compared to single-walled carbon nanotubes and iron oxide and silica nanoparticles.
2.4. Clay nanoparticles for nutrient delivery systems
As previously described, clay nanoparticles are biocompatible materials with a high internal 
space, a high ion exchange capacity, and a low toxicity that these properties make them ideal 
for the bioactive compound delivery systems. The nanoclay encapsulation system can be pre-
pared in a relatively simple and inexpensive process compared to other delivery systems. 
In addition to improving the solubility of the drug or active compounds, the nanoparticle 
encapsulation system has been considered for oral applications due to its high adhesion prop-
erties that are useful for molecules against GI barriers [49]. Choi’s research team reports an 
easy way of encapsulating the strongest antioxidant by MMT with cation exchange reaction 
(Figure 3(A)) [50]. γ-L-glutamyl-L-cysteinylglycine (GSH) is a cellular antioxidant protec-
tor (preserver) against reactive oxygen species by neutralizing free radicals. GSH stability 
can be increased by encapsulating GHS on MMT. The tested GSH-MMT on mice resulted 
in a significant increase in the bioavailability and high activity of antioxidants in the plasma 
(Figure 3(B)).
Figure 2. (A) Double-layer hydroxide and (B) cationic clay (MMT) [1].
Current Topics in the Utilization of Clay in Industrial and Medical Applications170
Clay nanoparticles have attracted a great deal of attention as a good candidate for packag-
ing of various materials, and it clearly demonstrates the increase in the sustainability and 
bioavailability of functional molecules.
2.5. The effect of clay mineral nanoparticles on the growth performance of internal 
organs and blood biochemistry of chickens compared to vaccines and antibiotics
Al-Beitawi et al. [51] investigated the effect of three levels of nanoclay minerals (1, 1.5, and 
2%) on the growth performance of internal organs and blood biochemistry of chickens com-
pared to vaccines and antibiotics. The experiment was conducted in nine diets for more than 
36 days [51]. Groups 1–3 were fed with diet without clay mineral nanoparticles, and group C1 
(positive with vaccines and antibiotics), C2 (positive only with vaccine), and C3 negative and 
without any of them (as control group). Treating groups with a similar diet to the levels men-
tioned earlier were done once or twice in a week. Performance of chickens, which fed with 2% 
clay nanoparticles, significantly improved in terms of body weight and feed conversion rates 
compared to control groups. With regard to blood biochemistry, high-density lipoprotein that 
is beneficial to the body was increased. Current results indicate that the mineral clay nanopar-
ticles at certain levels and doses improve the performance of chickens. Nanotechnology is 
considered as a new potential tool for improving broiler chickens. Researchers believe that the 
beneficial and positive effects of the use of mineral clay nanoparticles as an additive to the diet 
of broiler chicks may be due to several factors such as the concentration, dose, and nature of 
nanoparticles [51]. Desai et al. observed that a nano-supplement form would increase the sur-
face area, which may also increase the absorption and consequently the use of minerals [52]. 
In addition, Weiss et al. reported that the size of nanoparticles may increase the function or 
bioavailability of nutrients and compounds [53]. Mushtaq et al. reported that Na+ is the main 
cation of extracellular fluids involved in several functions including acid-base balance and 
amino acid absorption and glucose utilization that is beneficial for body growth, which may 
have a significant improvement in the growth performance of broiler chickens. On the other 
hand, the interest in using nanotechnology as a new tool in feeding broiler chicks shows that 
nanoparticles have very different physical and chemical properties from large particles [54]. In 
2013, Sawors et al. suggested that the number of muscle cells returns to genetic, environmen-
tal, and nutritional factors [55]. On the other hand, creating more accessible mineral resources, 
Figure 3. (A) X-ray pattern of (a) MMT and (b) GSH-MMT hybrid; and (B) GSH concentration in mice plasma [1].
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such as clay nanoparticles, can have positive effects on tissue development. According to the 
obtained results, it can be concluded that the mineral clay nanoparticles have a favorable 
effect on total serum protein and its cleft [51]. Nanoparticles have been reported to exhibit 
several new characteristics of transfer and absorption and also have more effective absorp-
tion. The researchers suggested that the superior performance of clay nanoparticles may be 
due to smaller size and larger surfaces that improve intestinal absorption [56].
2.6. Evaluation of the clay nanoparticles toxicity in epithelial cells
The extending continuous use of products containing nanoparticle for a wide range of appli-
cations has raised public health and safety concerns. Although products containing clay 
nanoparticles cannot be toxic, human contact during its preparation, production, or disposal 
process can have undesirable effects on health, which makes it necessary to evaluate the bio-
compatibility of clay nanoparticles. A group of researchers examined the effects of platelet 
toxicity (Bentone MA, ME-100, Cloisite Na+, Nanomer PGV, and Delite LVF) on human lung 
[57]. They used automated cells for the first time in real-time impedance imaging composi-
tions and also showed the effect of toxicity on the difference in the dose level and the time-
dependent of both types of clay nanoparticles [57]. Clay nanoparticles are used in a wide 
range of modern products such as electronic, food, clothing, tire, medicine, sunscreen, cos-
metics, sports equipment, polymer composites, bone implantation, controlled drug delivery 
systems, protective coatings (such as anti-corrosion, antibacterial, or antimolding), and for 
the synthesis of materials [58]. Clay nanoparticles, for example, plastic nanocomposites, are 
being developed to create unique devices for the next generation of biological applications, 
including antimicrobial agents, drug delivery, and cancer treatment [59–62].
2.7. Characterization of clay nanoparticles
SEM and TEM images are shown in Figure 4. In Table 1, a summary of the physiochemical 
properties of clay nanoparticles such as purity, specific surface area, zeta potential, and so on 
has been shown, which essentially affects the absorption and toxicity of nanoparticles.
2.8. Application of nanoclay-based composites in bone tissue engineering
The properties of MMT clay, such as its ability to absorb various types of toxins and the ability 
to cross the digestive tract (stomach and intestines) [60, 63–66], along with the ability to carry 
and transfer the drug [67–71], encourage human to use it in tissue engineering applications. 
It is reported that these nanoparticles are removed from the body because they cannot be 
absorbed by the intestines and they can also be dissolved by the acids in the stomach or intes-
tine [72]. In addition, clay is used as an edible laxative and an antidiabetes [72]. The above 
suggests that clay is suitable for tissue engineering applications, and decomposed products 
can be disposed without any effects on the normal body function. The use of MMT clay for 
bone tissue engineering applications needs further research. In the few studies that have been 
done in the past, MMT has been used to prepare nano-composites that examine the effect of 
adding clay on the mechanical and biological properties of polymers [73, 74]. Researchers 
have used 5-aminovaleric acid-modified MMT clay to prepare polymer composites for bone 
tissue engineering studies [75].
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2.9. Montmorillonite (MMT) as a carrier for drug delivery
Clay as a carrier for drug delivery is an amazing interdisciplinary field that brings together 
biology, materials science, and nanotechnology. Composites based on clay minerals have 
Figure 4. SEM and TEM images [57].
Geometry Nanoclay Chemical formula Purity 
(%)
Zeta 
potential 
(Mv)
Specific surface 
area (m2/g)
Tubular Halloysite MP1 Al
2
Si
2
O
5
(OH)
4
 × 2H
2
O 90 −41 65
Halloysite Al
2
Si
2
O
5
(OH)
4
 × 2H
2
O 90 −32.1 64
Platelet Nanomer PGV M+y(Al
2-y
Mg
y
)(Si
4
)O
10
(OH)
2
 × nH
2
O 100 −51.9 ND
ME-100 Na
2x
Mg
3.0-x
Si
4
O
10
(F
y
OH
1-y
)
2
100 −52.3 9
Delelite LVF (Si,Al)
8
(Al,Fe,Mg)
4
O
20
(OH)
4
,Xn,m(H
2
O) 100 −45.1 600
Bentone MA Na
0.4
Mg
2.7
Li
0.3
Si
4
O
10
(OH)
2
98 −36.6 600
Cloisite Na+ (Na,Ca)
0.33
(Al,Mg)
2
Si
4
O
10
(OH)
2
98 −48.6 800
ND, not tested.
Table 1. Physiochemical properties of clay nanoparticles [57].
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effect on a variety of fields, especially in pharmaceutical science. The tremendous variety of 
these natural materials has made the widespread collection of clays and polymers available 
to researchers [76–84]. The controlled drug delivery system is a method for the development 
of nanostructures and materials that can encapsulate high concentrations of materials, pass 
through a cell membrane, and release the drug in the target region for a given period. Clay 
minerals have exceptional (unique) characteristics such as low toxicity, better biocompatibil-
ity, and are guaranteed for a controlled drug release, and thus they are used in biological 
applications in pharmaceuticals, cosmetics, and even medical purposes [85, 86]. MMT is a 
natural mineral clay with a layered structure and prominent features such as a high internal 
surface area and cation exchange capacity (CEC), a high absorption capacity, and low toxicity 
[64, 87]. MMT with a net charge of the network can well be swollen in the presence of water 
and hydrophilic solvents, because positive-charged bioactive compounds can be inserted in 
interlayer (inside layer) spaces by electrostatic interaction. Many attempts have been made to 
develop MMT as a carrier for drug delivery, for example, to improve the water solubility of 
insoluble drugs and control the release of bioactive molecules [61, 83, 84, 88–93]. Biochemical 
properties, which make clay valuable for pharmaceutical applications, include high absorp-
tion capacity, high internal surface, high exchange ability, interlayer spatial reactions with 
drug molecules, chemical moisture, and low toxicity [61, 72, 83, 84, 94–96]. Clay is widely 
used as an active agent and an additive in pharmaceutical formulations [97–99]. In pharma-
ceuticals, MMT has found extensive applications as a suspension and a stabilizer, as well 
as an absorbent and clear factor. Also, MMT has been used as a drug carrier or an additive 
in pharmaceutical formulations [71, 72, 99–104]. The MMT’s ion exchange capacity provides 
the possibility of replacing Na + with other organic and inorganic cations to increase perfor-
mance. It also causes the use of MMT and other clay species as a tissue regeneration agent [71, 
76–84, 96, 105] (Table 2).
The authors have shown that increasing the concentration of silicate nanoparticles increases 
the mechanical strength of polymer nanoparticles [107]. Wang et al. prepared 2008 complex 
Drug
5-Flurouracil (anticancer) Ibuprofen (nonsteroidal anti-inflammatory)
Amino acids BSA (model protein)
Plasmid DNA (gene delivery) Donepezil (Alzheimer)
Paclitaxel (anticancer drug) Docetaxel (anticancer drug)
Lidocaine (local anesthetic drug) 5-Fluorouracil (anticancer drug)
Glutathione (antioxidant) Doxorubicin (anticancer drug)
Ibuprofen (anti-inflammatory) Buspirone hydrochloride (antianxiety)
Captopril (hypertension) Timolol maleate (β-adrenergic blocking agent)
Vitamin B1 Ranitidine hydrochloride (antacid)
Quinine (antimalarial drug) Procainamide hydrochloride (antiarrhythmia drug)
Tamoxifen (anticancer drug) Epidermal growth factor (tissue engineering)
Table 2. List of drugs used in clay as carrier [106].
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chitosan-montmorillonite (HTCC/MMT) nanocomposites for the application as protein carri-
ers [103]. In 2010, Shhameli et al. showed a new green color combination for MMT/chitosan 
nanoparticles (CS) and its antibacterial actions [108]. Lee and Fu found that the properties of 
the released drug can be controlled by the charge of N-isopropylacrylamide/MMT nanocom-
posites [109]. In general, the ability to exchange ions, interoperability, and biocompatibility 
of MMT has made it an ideal candidate for drug delivery. In addition to pharmaceutical use, 
MMT and its nanocomposites are bioactive agents that have a wide range of applications. 
MMT can play an important and powerful role in intestinal detoxification, since it can absorb 
food, microbial, and metabolic toxins and, surprisingly, can increase the hydrogen ions in 
acidosis. Also, MMT can be used for edible purpose for digestive system detoxification, con-
stipation reduction, internal parasite eradication, strengthening of the immune system, liver 
detoxification, reduction of stomach pain, and poisoning by bacteria. Revitalizing drugs and 
tissue engineering programs include bone remodeling as growth agents and wound dressing. 
The network structure of this is shown in Figure 5 [106].
MMT is widely used in the treatment of bone pain and damaged muscle, chronic headache, open 
wounds, special skin conditions (acne, eczema, red seeds on the skin, etc.), diarrhea, hemorrhoids, 
stomach ulcers, intestinal problems, anemia, rapid recovery of injuries (bruises, stretching, burns, 
etc.), severe bacterial infections, skin rejuvenation, and various health issues. Therefore, it can be 
beneficial to health because all its activities are physical and there is no chemical reaction on the 
body. After taking, no or small amount of MMT is absorbed in the digestive system and the rest 
is excreted (repulsed) by feces. According to the ISI database, interest in drug delivery by clay 
shows a significant increase in scientific publications (Figure 6) [106].
2.10. Mechanisms of drug-clay interactions
According to the tests conducted, the basis of controlled drug delivery is the use of laminar 
(layer) interference. Interference may occur by mixing sub-solids (ion converters) with ionic 
Figure 5. MMT network structure [106].
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material in solution. In biological fluids, “anti-ions” can move the drug into the substrate and 
transfer it to the body, so the converter can be removed or decomposed at the end (Figure 7) 
[106]. Smectites, especially MMT and saponite, have been further studied due to their ionic 
exchange capacity compared to other silicates (talc, kaolin, and fibrous mineral clay). A specific 
mechanism depends on factors such as functional groups and chemical physical properties 
Figure 7. Mechanism of release of MMT and absorption in the body [106].
Figure 6. The number of studies on the use of clay nanoparticles as carrier for drug delivery [106].
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of organic compounds [109–111]. Silicate-based composites exhibit a good inhibitory (barrier) 
effect due to complicated intrusive pathways that small molecules need to undergo (pass) in 
order to clarify the material (Figure 8) [112].
2.11. The latest MMT pattern used in drug delivery systems
Lin et al. showed the 5-FU interference on the MMT inner layers [61]. 5-FU-MMT was deter-
mined and the successful interference of the drug in MMT was confirmed by opening the 
inner layer and changing the XRD pattern to the lower 2θ angle, and the results are presented 
in Figure 9. Finally, it can be concluded that the total amount of 5-FU absorbed in MMT is 
approximately 87.5 mg/g MMT.
Park et al. reported the placement of donepezil molecules on clay (Laponite, LA, saponite, SA 
and MMT) and provided descriptive information, which confirmed the well-located done-
pezil molecules in the inner layers of clay (Figure 10) [91]. The absorption amount and the 
donepezil molecular structure depend on the cationic exchange ability of clay, which has 
designed drug release patterns. The rate of release can be increased easily by using a large 
cationic polymer. The Eudragit® E-100 hybrid, coated with such a polymer, shows the release 
of drug at higher speeds over a short period. Therefore, nanoclay materials are proposed as 
an advanced carrier for drug delivery with a controllable release feature.
Figure 8. Mechanism of drug release from nanocomposites [106].
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2.12. 2D clay nanoparticles for drug delivery in cancer treatment
Two-dimensional kaolinite clay nanoparticles are used in the drug delivery system. The 
increasing of spacing of the kaolinite nanoparticles from 0.72 to 4.16 nm is due to the inter-
ference of guest species with different chain lengths of organic materials that can increase 
the drug delivery efficiency and reduce the toxicity of doxorubicin (DOX). The kaolinite 
(Kaolin) and kaolin compounds show a high level of biocompatibility and low toxicity against 
Figure 10. The schematics of donepezil interference in clay nanomaterials: (a) the dual-layer composition and (b) the 
single-layer composition [106].
Figure 9. XRD patterns of MMT and 5-FU-MMT [106].
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pancreatic cancer cells, gastric cancer, prostate cancer, breast cancer, esophageal cancer, and 
thyroid cancer diagnosis. However, lung cancer and leukemia require structural harder com-
pounds for drug delivery. DOX-Kaolin and its internal contents exhibit more drug release 
rates in acidic environment than in the neutral environment. The use of two-dimensional 
clay nanoparticles for a drug delivery system can pave the way for high-performance nano-
therapies with superior antitumor efficacy and significant reduction of side effects. As shown 
in Figure 11, it is used for the treatment of tumors [113].
2.13. An overview of clay chemistry
Broadly, clay minerals are structured of two principal units: tetrahedral (T) and octahedral 
(O) sheets [114, 115]. Each tetrahedron consists of a central cation (mostly Si4+) coordinated 
to four  O 2− anions and linked to adjacent tetrahedra through three shared oxygens on the 
corners (basal oxygens Ob) forming an infinite 2D hexagonal mesh (Figure 12). The fourth 
O 2− (apical oxygen Oa) remains unshared, lying perpendicular to the tetrahedral sheet, and 
is the main site of interaction with the octahedral sheet. Each octahedron consists of a metal 
cation ( M n+ ) coordinated to six  O 2− and/or  OH − anions. Adjacent octahedra are linked to each 
other by sharing edges (two  O 2− or   OH − ), forming an octahedral sheet. If Mn is divalent ( Mg 2+ ), 
a trioctahedral or a brucite-like sheet is produced, if it is trivalent ( Al 3+ ), then two out of every 
three octahedral sites are occupied, leaving a vacant site and the generation of a dioctahedral 
or a gibbsite-like sheet. Clays can be classified into 1:1 and 2:1 types according to the layering 
Figure 11. Schematic design and kaolin and kaolin compounds for the treatment of tumors [113].
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of T and O sheets. 1:1 (or T-O) clay minerals consist of a single T sheet linked to a single O 
sheet, and 2:1 (or T-O-T) clay minerals consist of a single O sheet sandwiched between two T 
sheets (Figure 12, Table 3).
In the case of smectites, an octahedral sheet of metal oxides (usually  Mg 2+ or  Al 3+ ) is sandwiched 
between two tetrahedral silica sheets. Two types of charges originate on the smectite clay 
particle: (1) permanent negative charges on the surface due to isomorphous cation substitu-
tion in the tetrahedral and/or octahedral sheets (e.g.,  Li + for Mg2+ in Laponite) balanced by 
exchangeable cations such as Na or  Ca 2+ in the interlayer gallery. (2) Positive (amphoteric) 
charges on the edges due to broken Si-O, Al-OH, and Mg-OH groups. At pH < Zero Point of 
Charge (ZPC), these edge charges become positive with anion exchange capacity, while at 
pH > ZPC, they become negative with a cation exchange capacity. Adapted with permission 
[116]. Copyright 2014, John Wiley and Sons.
Clay structure and reactivity. The reactivity of clays is largely a function of their swelling capac-
ity. Kaolinite (of the 1:1 clay family) and talc and pyrophyllite (of the 2:1 clay family) possess 
no structural charges and consequently are non-swelling and of low adsorption capacity. 
The high-layer charge on vermiculite and illite restricts their swelling and gelling tendency 
although their surface area and CEC are relatively high. Smectites are characterized by their 
relatively low-layer charge which allow their particles to undergo complete dissociation in 
water and give them interesting rheological/gel-forming properties and surface reactivity. 
Halloysite is formed of hydrated 1:1 layers which role up into nanotubes (alumina sheet on 
the inside and silica sheet on the outside surface) and sepiolites (and palygorskite) are charac-
terized by their inverted 2:1 ribbon structures. Such arrangements confer large SSA, porosity, 
and sorptive capacity. Adapted with permission [117].
2.14. Morphology
We focused on the investigation of the potential toxic effects caused by nanoclay particles 
currently used in tons in several industrial applications. Bentonite, montmorillonite, and 
Figure 12. The structure of smectites. Clays are formed of layered tetrahedral (T) and octahedral (O) sheets.
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kaolin are platy clay particles ranging from nanometers to micrometers, whereas halloysite 
nanotubes are hollow rod-like particles having a lumen diameter of ∼20 nm and a tube length 
ranging from 300 nm to 2 μm. Spherical silica nanoparticles were also used as a material mim-
icking the outer silica layer of the clays. Graphene oxide nanosheets having the shape and size 
close to smectite clays were selected as a material with a relatively high reported toxicity, 30, 
which was also confirmed in our study. The typical AFM images demonstrating the geometry 
and sizes of nanoparticles used in this study are given in Figure 13.
The nanoparticles used were suspended in water and added to protozoan media at a range 
of concentrations. Prior to toxicity investigation, the hydrodynamic diameters and surface 
potential of nanoparticles were determined using dynamic light scattering (DLS) and electro-
phoretic mobility measurements in water (Table 4) [118].
2.15. Ecotoxicological profile
No ecotoxicological studies of nanoclay have been identified as of November 30, 2010. Since 
clay is a naturally occurring material for which environmental organisms have adapted 
throughout evolution, the inherent toxicity is expected to be low; however, issues related to 
small particle sizes may occur [78].
2.16. Toxicological profile
Today, few studies are available, and there is limited knowledge about the toxicity of nano-
clays and the chemical derivatives that may be generated during the production and process-
ing of polymer nanoclay composites. However, in general, nanoclay is not considered to pose 
a major health risk although a possible content of crystalline quartz may constitute a risk. 
Family group Species Chemical 
formula
Charge/formula 
unit
CEC Particle size (nm)
1:1 Serpentine-
kaolin
Halloysite Al
2
Si
2
O
5
(OH)
4
.
nH
2
O
~0 [114] ~10 meq/100 g 
[121, 122]
Nanotube 
diameter of 
~50 nm, lumen of 
~15 nm, and length 
of ~1 mm [119, 126]
2:1 Smectites Montmorillonite Na
m
(Al
2-m
Mg
m
)
Si
4
O
10
(OH)
2
.
nH
2
O
~0.2–0.6 [114] ~80–150 meq/100 g 
[121, 122]
~80–300 nm 
diameter and ~ 
1 nm thickness 
[127, 129]
Laponite 
(synthetic 
hectorite)
Na
h
(Mg
3-h
Li
h
)
Si
4
O
10
(OH)
2
.
nH
2
O
~25–30 nm 
diameter and ~ 
1 nm thickness 
[120, 123]
Sepiolite-
palygorskite
Sepiolite X*(Mg, Al, Fe
3þ)
4
(Si,Al)
6
O
15(OH)
2
.nH
2
O
— ~4–40 meq/100 g 
[124, 125]
Nanofiber 
diameter of 
~15 nm and length 
of ~200–400 nm 
[124, 128]
Table 3. Key clay mineral species explored for tissue engineering and regenerative medicine applications with their 
relevant structural/compositional properties.
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Furthermore, functionalized nanoclays containing quaternary ammonium or phosphonium 
functional groups on the surface are described as potentially problematic, as ammonium and 
phosphonium ions in their pure form can cause asthma symptoms (NFA, 2010) [78].
3. Conclusions
Clay nanoparticles have traditionally been used in many applications such as treatment, skin 
chemotherapy, and medicine to improve the human health and life. In addition, they have 
recently been developed as additives, lubricants, and active materials in pharmaceutical formu-
lation. Although their application in food science is relatively limited, they have the potential to 
Particles Hydrodynamic diameter, 
nm
Zeta-potential, 
mV
AFM measured dimensions
Halloysite 510 ± 12 −25 ± 3 50 nm diameter, 400–1500 nm length
Kaolin 930 ± 22 −36 ± 1 300–700 nm width, 30–100 nm thick
Montmorillonite 1600 ± 60 −29 ± 1 300–600 nm width, 10–50 nm thick
Bentonite 3040 ± 660 44 ± 2 ∼4 μm width, ∼100 nm thick
Silica 122 ± 3 −39 ± 6 120 nm diameter
Graphene oxide 1940 ± 90 −47 ± 2 2000 nm width, 2–10 nm thick
Table 4. Hydrodynamic diameters, zeta-potential values, and AFM measured sizes of nanoclay particles, silica 
nanospheres, and graphene oxide nanoflakes.
Figure 13. Typical AFM images of (a) bentonite, (b) montmorillonite, (c) kaolin, (d) halloysite, (e) silica, and (f) graphene 
oxide nanoparticles.
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deliver nutrients. Their unique structure is able to place bioactive molecules in the interior space. 
Nanoparticles that contain nutrients have the ability to protect GI against the environment and 
control the release features. They can enter the cell and with their adhesion properties facilitate 
the transfer of GI molecules against barriers. Also, they exhibit low toxicity. Research on the 
development of clay nanoparticles based on oral delivery systems for nutrients or functional 
compounds indicates that they are effective in protecting and controlling deliveries and also 
contributing to the increased bioavailability. The promising potential of the clay nanoparticles 
makes a new perspectives for the development of nano-based oral delivery systems. The toxic-
ity of nanomaterials is a very important issue. In general, the results show that higher doses of 
clay nanoparticles result in the death of cells, which is a concern for medical applications. As 
an important point in the application of clay nanoparticles in delivery systems, to achieve clay-
based controlled delivery systems, one of the best ways is to place organic molecules on the 
underlying layers of mineral clay. Besides, its composites can be used to improve properties.
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